A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna’s COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Rochelle Walensky to sign off on the vaccine for that age group, offering a second option along with…
The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and by Moderna for children as young as 6 months on Friday, adding the final group to the nation’s vaccine program. The regulator said Moderna’s MRNA The two-dose vaccine is now authorized…
A day after a panel of advisers to the Food and Drug Administration endorsed a second brand of COVID-19 vaccine for school-age children and teens, the same panel will reconvene to discuss vaccines for children under the age of five, the final group to be added to the US program. The group voted unanimously that…
An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna MRNA, + 2.18% The vaccine could become a second choice for children in that age group, along…
Federal health officials said Sunday that Pfizer’s COVID-19 vaccine appears safe and effective for children below the age of 5, clearing another hurdle on the path toward adding that group to the nation’s vaccine program. The FDA posted its analysis of the Pfizer PFE shot ahead of a Wednesday meeting where outside experts will vote…
Children under 5 years old could begin to receive vaccinations against COVID-19 as early as June 21, a Biden administration official said Thursday, in a boost for anxious parents for their very young children to be added to the program. Dr. Ashish Jha, the White House’s COVID response coordinator, told reporters at a briefing: “We…
